Yi Zang

653 total citations · 1 hit paper
12 papers, 434 citations indexed

About

Yi Zang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Yi Zang has authored 12 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Yi Zang's work include Pancreatic and Hepatic Oncology Research (3 papers), Autophagy in Disease and Therapy (3 papers) and MicroRNA in disease regulation (2 papers). Yi Zang is often cited by papers focused on Pancreatic and Hepatic Oncology Research (3 papers), Autophagy in Disease and Therapy (3 papers) and MicroRNA in disease regulation (2 papers). Yi Zang collaborates with scholars based in China, United States and Australia. Yi Zang's co-authors include Don L. Gibbons, Yanan Yang, Chad J. Creighton, Young‐Ho Ahn, Nishan Thilaganathan, Gregory J. Goodall, Philip A. Gregory, Wei Lin, Jonathan M. Kurie and Daniel C. Moreira and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Controlled Release and Oncotarget.

In The Last Decade

Yi Zang

10 papers receiving 431 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis

2024 40 citations Cong Yan, Xuelian Ren et al. iScience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Zang China	9	345	227	95	46	20	12	434
Gloria Ros Italy	9	314 0.9×	219 1.0×	75 0.8×	32 0.7×	20 1.0×	13	378
Yue-Yang Lei China	4	353 1.0×	230 1.0×	94 1.0×	30 0.7×	23 1.1×	4	427
Hsuan-Yu Peng Taiwan	9	285 0.8×	219 1.0×	72 0.8×	29 0.6×	29 1.4×	10	368
Rongxia Liao China	10	292 0.8×	245 1.1×	118 1.2×	28 0.6×	32 1.6×	18	429
Verónica Moncho-Amor Spain	8	263 0.8×	128 0.6×	96 1.0×	35 0.8×	34 1.7×	15	366
Linda Minotti Italy	8	239 0.7×	251 1.1×	133 1.4×	42 0.9×	14 0.7×	10	369
Yuanhui Lai China	10	274 0.8×	192 0.8×	68 0.7×	60 1.3×	18 0.9×	15	352
Baocun Sun China	8	298 0.9×	231 1.0×	100 1.1×	44 1.0×	44 2.2×	9	399
Namrata Bhatnagar United States	5	270 0.8×	187 0.8×	94 1.0×	53 1.2×	45 2.3×	6	397
Arianna Giacobbe Italy	7	385 1.1×	252 1.1×	188 2.0×	43 0.9×	28 1.4×	7	520

Countries citing papers authored by Yi Zang

Since Specialization

Citations

This map shows the geographic impact of Yi Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zang more than expected).

Fields of papers citing papers by Yi Zang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zang. The network helps show where Yi Zang may publish in the future.

Co-authorship network of co-authors of Yi Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zang. A scholar is included among the top collaborators of Yi Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zang. Yi Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Zhang, Zhe, Zhi-Ming Shao, Xianfeng Gu, et al.. (2025). Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation. Journal of Controlled Release. 387. 114187–114187.

2.

Zhu, Chengyue, Junqing Li, Yi Zang, et al.. (2025). Controlling nosocomial transmission of respiratory infections in neurological wards: insights from COVID-19 pandemic data. International Journal for Quality in Health Care. 37(3).

3.

Yan, Cong, Xuelian Ren, Shankang Qi, et al.. (2024). Sirtuin 1/sirtuin 3 are robust lysine delactylases and sirtuin 1-mediated delactylation regulates glycolysis. iScience. 27(10). 110911–110911. 40 indexed citations breakdown →

4.

Li, Tong, Xu Liu, Bin Xu, et al.. (2020). SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells. Cell Proliferation. 53(4). e12799–e12799. 20 indexed citations

5.

Wu, Wei, Xu Liu, Yi Zang, et al.. (2018). Tp53 Mutation Inhibits Ubiquitination and Degradation of WISP1 via Down-Regulation of Siah1 in Pancreatic Carcinogenesis. Frontiers in Pharmacology. 9. 857–857. 14 indexed citations

6.

Qian, Yuting, Tingting Bai, Juanjuan Li, et al.. (2018). Magnetic-Guided Capsule Endoscopy in the Diagnosis of Gastrointestinal Diseases in Minors. Gastroenterology Research and Practice. 2018. 1–8. 8 indexed citations

7.

Zang, Yi, Lei Zhu, Tong Li, et al.. (2018). EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc. Gastroenterology Research and Practice. 2018. 1–12. 10 indexed citations

8.

He, Xiangyi, Qiwen Ben, Weiyi Wang, et al.. (2017). Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress. Oncotarget. 8(43). 74299–74311. 4 indexed citations

9.

Wang, Qi, Juanjuan Li, Wei Wu, et al.. (2016). Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer. Oncotarget. 7(10). 11208–11222. 19 indexed citations

10.

Du, Zixiu, Shengnan Xiang, Yi Zang, et al.. (2014). Polyspermine imine, a pH Responsive Polycationic siRNA Carrier Degradable to Endogenous Metabolites. Molecular Pharmaceutics. 11(10). 3300–3306. 10 indexed citations

11.

Yang, Yanan, Young‐Ho Ahn, Don L. Gibbons, et al.. (2011). The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200–dependent pathway in mice. Journal of Clinical Investigation. 121(4). 1373–1385. 161 indexed citations

12.

Roybal, Jonathon D., Yi Zang, Young‐Ho Ahn, et al.. (2010). miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1. Molecular Cancer Research. 9(1). 25–35. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact